source
- FDA nominee Heidi Overton pledges faster, more efficient regulation to keep pace with ChinaDuring a Senate hearing, Heidi Overton was confirmed as the nominee to lead the U.S. Food and Drug Administration. She outlined her priorities for the agency. Overton said the FDA must move faster…
- Gilead pushes further into immunology, touts inflammation drug pipelineGilead Sciences’ senior leadership has repeatedly emphasized the company’s long‑term ambition to expand beyond its virology roots into the inflammatory and autoimmune space. The messaging, delivere…